The average weight loss after 72 weeks of treatment was 1520% (compared to 3.1% with a placebo), and 3057% of participants lost at least 20% of their body weight [118]
Some are clinically meaningful clues that point toward systemic disease, medication side effects, or conditions that deserve a closer look
Because tirzepatide can be potent, even route and dose strategy should be discussed carefully with a provider
How to Get Started If you believe you may qualify for the Medicare GLP-1 Bridge and would like to discuss GLP-1 therapy with our team: Step 1: Your Office Visit and Prescription At your visit, your BWPC clinician will assess your eligibility against the Bridge criteria, document your starting BMI and qualifying condition, and write the prescription
Long-term safety : No long-term human data exist for anti-aging use
Combined, these effects can take a heavy toll on an athletes performance